| 영문 | gigantism | 한글 | 거인증 |
|---|---|---|---|
| 설명 | 뇌하수체의 성장호르몬을 분비하는 세포에서 종양이 생겼을 경우에 과도한 성장 호르몬의 생성으로 발생되는 병이다. 뼈에서 길이의 성장을 담당하는, 연골로 구성되어 있는 부위인 뼈끝이 연골에서 뼈가 생성 되어서 뼈의 길이의 성장이 일어난다. 성장이 다 된 뼈에서는 이 연골판이 없어지게 되어 양쪽의 뼈가 융합이 되고 이것이 있던 부위에 하나의 선만이 남게 된다. 뼈끝 융합이 일어나기 전에 종양이 생겼을 때는 거인증(giantism)이 일어나지만 뼈끝융합이 일어난 후에 생겼을 때는 말단비대증(acromegaly)이라는 병이 일어난다. 거인증은 소아기에는 매우 드물며, 대부분이 과도한 성장이 있는 사춘기에 일어난다. 과도한 성장호르몬의 분비에 의해서 뼈, 연골, 섬유조직 등의 과도한 성장이 있게 된다. 일반적으로 자각 증상은 없는 경우가 보통이며 있는 경우도 있지만 아주 경미하다. 머리뼈나 아래턱뼈가 아주 두터워지고 모든 뼈의 굵기나 크기가 증가된다. 뼈의 기능은 모두 정상이나 근육의 힘이 약해 있는 것이 대부분이다. 검사상으로 혈액중에 성장 호르몬치가 높으며, 치료는 외과적으로 뇌하수체에 생긴 종양을 절제하는 방법과 방사선을 쬐어서 그 종양을 없애는 방법이 있다. |
||
| LA | lactic acid; large amount; laser angioplasty; late abortion; late antigen; latex agglutination; left... |
|---|---|
| DGS | decompression sickness; developmental Gerstmann syndrome; diabetic glomerulosclerosis; Di George seq... |
| DGSX | X-linked dysplasia gigantism syndrome |
| EMG | electromyogram, electromyography; eye movement gauge; exomphalosmacroglossia-gigantism [syndrome] |
| TAE | Trans-Arterial(-Catheter) Embolization Angiography와 동시에 Gel Form과 CTx Agent의 Mixed m... |
| EMLA | Eutectic Mixture of Local Anaesthetics |
|---|---|
| LAN | Local Area Network |
| LCBF | Local CBF |
| LFP | Local Field Potentials |
| L.G.A | Local Government Area |
| acromegalic gigantism | A form of pituitary gigantism in which the signs of acromegaly accompany abnormal height. (05 Mar 2000) |
|---|---|
| gigantism | A condition where there is over-production of growth hormone by the pituitary gland in a child before the bone growth plates close, resulting in excessive long bone growth. (27 Sep 1997) |
| cerebral gigantism | A syndrome characterised by increased birth weight and length (above 90th percentile), accelerated growth rate for the first 4 or 5 years without elevation of serum growth hormone levels, and then reversion to normal growth rate; characteristic facies include prognathism, hypertelorism, antimongoloid slant, and dolichocephalic skull; moderate mental retardation and impaired coordination are also associated. See: Sotos' syndrome. (05 Mar 2000) |
| pituitary gigantism | Excessive growth due to overactivity of the pituitary gland (specifically of the anterior pituitary). (12 Dec 1998) |
| primordial gigantism | Unusually large size from birth due to familial or genetic factors or intrauterine environment (e.g., maternal prediabetic state) and not to hyperpituitarism. (05 Mar 2000) |
| eunuchoid gigantism | Gigantism with deficient development of sexual organs; may be of pituitary or gonadal origin; gigantism accompanied by body proportions typical of hypogonadism during adolescence. (05 Mar 2000) |
| focal gigantism | <radiology> Neurofibromatosis, AVM, Klippel-Trenaunay-Weber syndrome, Beckwith-Wiedemann syndrome, Parks-Davis syndrome, haemangioma, JRA (12 Dec 1998) |
| foetal gigantism | Excessive foetal or newborn size, e.g., cerebral gigantism and infants of diabetic mothers. (05 Mar 2000) |
| anaesthesia, local | Anaesthesia confined to one part of the body. Infiltration anaesthesia produces local anaesthesia by deposition of a local anaesthesia solution in the area of small, terminal nerve endings. (12 Dec 1998) |
| anaesthetics, local | Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fibre. In contact with a nerve trunk, these anaesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. Nearly all local anaesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. They are commonly used not only in the peripheral nervous system, but also for spinal anaesthesia. The many drugs that have local anaesthetic actions as a side effect but are not used for their local anaesthetic action are not included here. (12 Dec 1998) |
| anti-infective agents, local | Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from disinfectants, which are used on inanimate objects. (12 Dec 1998) |
| neoplasm recurrence, local | The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. (12 Dec 1998) |
| local | Restricted to or pertaining to one spot or part, not general. Origin: L. Localis (18 Nov 1997) |
| local anaemia | Anaemia resulting from a decreased supply of blood to a part, as in the occlusion of a vessel. (05 Mar 2000) |
| local anaesthesia | The use of a local anaesthetic (usually injected into the tissue) results in a small region of anaesthesia (numbness). Lidocaine (Xylocaine) or (Marcaine) are commonly used. Origin: Gr. Aisthesis = sensation (27 Sep 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|